Published in Dig Dis Sci on September 01, 2001
Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy | NCT03191604
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol (2015) 3.22
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A (2011) 1.29
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg (2006) 1.12
Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag (2007) 1.00
Barrett's esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) (2013) 0.83
Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am (2015) 0.79
Barrett's Esophagus: Emerging Knowledge and Management Strategies. Patholog Res Int (2012) 0.78
The patterns of reflux can affect regression of non-dysplastic and low-grade dysplastic Barrett's esophagus after medical and surgical treatment: a prospective case-control study. Surg Endosc (2014) 0.77
Surveillance in Patients With Barrett's Esophagus for Early Detection of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol (2015) 0.76
Barrett's oesophagus and adenocarcinoma. World J Surg Oncol (2004) 0.76
Improved specimen adequacy using jumbo biopsy forceps in patients with Barrett's esophagus. World J Gastroenterol (2015) 0.75
Acetic acid chromoendoscopy: Improving neoplasia detection in Barrett's esophagus. World J Gastroenterol (2016) 0.75
Endoscopic management of Barrett esophagus. Nat Rev Gastroenterol Hepatol (2011) 0.75
Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol (2016) 0.75
Barrett's Esophagus: Diagnosis and Management. Gastrointest Endosc (2017) 0.75
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Cancer statistics, 1998. CA Cancer J Clin (1998) 6.26
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol (1998) 4.68
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol (1997) 4.52
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med (1985) 4.30
Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology (1992) 3.86
Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56
The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology (1996) 3.11
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06
Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital. Gut (1997) 1.90
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63
A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol (1994) 1.59
Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am (1991) 1.42
Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? Ann Intern Med (1987) 1.31
Barrett's oesophagus. J Gastroenterol Hepatol (1991) 1.24
The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol (1988) 1.24
Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. Am J Surg Pathol (1995) 1.17
Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg (1994) 1.14
Surveillance for Barrett's oesophagus in the UK. Br J Surg (1999) 1.10
Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol (1998) 1.07
Risk stratification and long-term results after surgical treatment of carcinomas of the thoracic esophagus and cardia. A 25-year retrospective study. J Thorac Cardiovasc Surg (1990) 1.04
Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Lab Invest (1989) 0.99
Stage II esophageal carcinoma: the significance of T and N. J Thorac Cardiovasc Surg (1996) 0.99
Barrett's esophagus and adenocarcinoma. Annu Rev Med (1987) 0.99
Recent developments in the molecular characterization of Barrett's esophagus. Dig Dis (1998) 0.98
Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy (1995) 0.94
Multifocal heterogeneity in villin and Ep-CAM expression in Barrett's esophagus. Int J Cancer (1996) 0.92
Extent of resection and lymphadenectomy in early Barrett's cancer. Dis Esophagus (1997) 0.75
Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea. Lancet (1994) 4.23
Mycobacteria as a possible cause of inflammatory bowel disease. Lancet (1978) 2.94
Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut (1991) 2.64
Jejunal efflux in short bowel syndrome. Lancet (1990) 2.52
Diagnosis of giardiasis by specific IgM antibody enzyme-linked immunosorbent assay. Lancet (1986) 2.04
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut (2002) 1.92
Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut (1978) 1.87
Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology (1997) 1.86
Crucial role for 5-HT in cholera toxin but not Escherichia coli heat-labile enterotoxin-intestinal secretion in rats. Gastroenterology (1998) 1.85
Gossypiboma revisited: a case report and review of the literature. J R Coll Surg Edinb (1998) 1.82
Inflammation in ileal reservoirs: 'pouchitis'. Gut (1990) 1.80
Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J Virol (2000) 1.78
Dilutional diarrhoea: under-diagnosed and over-investigated. Eur J Gastroenterol Hepatol (2000) 1.75
Low gluten diet in the treatment of adult coeliac disease: effect on jejunal morphology and serum anti-gluten antibodies. Gut (1988) 1.70
Sexual problems among married ileostomists. Survey conducted by The Ileostomy Association of Great Britain and Ireland. Gut (1977) 1.67
Intestinal transit in anxiety and depression. Gut (1996) 1.67
Research misconduct. Gut (1997) 1.67
One-minute endoscopy room test for Campylobacter pylori. Lancet (1988) 1.64
Cimetidine and ranitidine in duodenal ulcer. Br Med J (1980) 1.63
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut (1998) 1.62
Travellers' diarrhoea. BMJ (1993) 1.57
Bleeding from peptic ulcers and use of non-steroidal anti-inflammatory drugs in the Romford area. Br Med J (Clin Res Ed) (1985) 1.51
Retractions in Gut 10 years after publication. Gut (2001) 1.49
Diagnostic and therapeutic efficacy of barium meal examination: a prospective evaluation in general practice. BMJ (1989) 1.46
The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology (2000) 1.43
Dysphagia in a patient with lupus and review of the literature. Lupus (2002) 1.41
Irritable bowel syndrome. QJM (1995) 1.40
Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut (2002) 1.38
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res (1998) 1.36
Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology (1990) 1.35
The use of rats associated with a human faecal flora as a model for studying the effects of diet on the human gut microflora. J Appl Bacteriol (1987) 1.35
Mammalian bile promotes growth of Giardia lamblia in axenic culture. Trans R Soc Trop Med Hyg (1983) 1.33
K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology (1997) 1.29
Cimetidine in the prevention of gastric ulcer relapse. Postgrad Med J (1979) 1.29
Selective affective biasing in recognition memory in the irritable bowel syndrome. Gut (1993) 1.28
Description and characterization of a surface lectin from Giardia lamblia. Infect Immun (1986) 1.28
Water and solute absorption from a new hypotonic oral rehydration solution: evaluation in human and animal perfusion models. Gut (1992) 1.26
Water, electrolyte, glucose, and glycine absorption in rat small intestinal transplants. Gastroenterology (1988) 1.24
Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer (2003) 1.22
Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut (1997) 1.22
Natural history of Giardia infection of infants and children in rural Guatemala and its impact on physical growth. Am J Clin Nutr (1986) 1.20
Promotion of gallbladder emptying by intravenous aminoacids. Lancet (1993) 1.19
Attachment of Giardia lamblia to rat intestinal epithelial cells. Gut (1988) 1.18
Efficacy of oral rehydration solutions in a rat model of secretory diarrhea. J Pediatr Gastroenterol Nutr (1988) 1.17
Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut (1992) 1.16
Controlled trial of small bipolar probe in bleeding peptic ulcers. Lancet (1986) 1.16
HLA-A and -B antigens in inflammatory bowel disease. Gut (1986) 1.16
Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology (2001) 1.16
Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol (1998) 1.15
5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut (1994) 1.15
A national training programme for gastroenterology and hepatology. Gut (1996) 1.14
Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients. Ther Drug Monit (2000) 1.13
The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut (1998) 1.13
Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut (2000) 1.13
Characterization of Helicobacter pylori PldA, a phospholipase with a role in colonization of the gastric mucosa. Gastroenterology (1999) 1.12
Action of centrally mediated autonomic stimulation on human upper gastrointestinal transit: a comparative study of two stimuli. Gut (1987) 1.11
Attachment of Giardia lamblia trophozoites to a cultured human intestinal cell line. Gut (1995) 1.11
Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther (1994) 1.11
Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor. FEBS Lett (1998) 1.11
Functional analysis of the roles of FliQ and FlhB in flagellar expression in Helicobacter pylori. FEMS Microbiol Lett (1999) 1.10
Screening for asymptomatic colorectal cancer. BMJ (1997) 1.10
Effects of bile and bile salts on growth and membrane lipid uptake by Giardia lamblia. Possible implications for pathogenesis of intestinal disease. J Clin Invest (1985) 1.10
Tropical enteropathy: a T-cell-mediated crypt hyperplastic enteropathy. Eur J Gastroenterol Hepatol (2001) 1.10
Effect of bicarbonate, acetate, and citrate on water and sodium movement in normal and cholera toxin-treated rat small intestine. Scand J Gastroenterol (1989) 1.09
Giardia lamblia: evaluation of roller bottle cultivation. Exp Parasitol (1982) 1.07
The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy. J Med Microbiol (1984) 1.07
Reappraisal of the 'lectin hypothesis' in the aetiopathogenesis of coeliac disease. Clin Sci (Lond) (1986) 1.06
Ambulatory small intestinal motility in 'diarrhoea' predominant irritable bowel syndrome. Gut (1994) 1.05
Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Pharmacol Ther (1990) 1.05
Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. Gut (1981) 1.05
Delayed puberty and response to testosterone in a rat model of colitis. Am J Physiol Regul Integr Comp Physiol (2001) 1.04
Mycobacterium paratuberculosis and Crohn's disease. Gut (1991) 1.03
Further data on skin testing with mycobacterial antigens in inflammatory bowel disease. Lancet (1980) 1.03
Male gonadal function in coeliac disease: 2. Sex hormones. Gut (1983) 1.02
Controlled trial of endoscopic injection treatment for bleeding from peptic ulcers with visible vessels. Lancet (1992) 1.02
Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines. Br J Cancer (1999) 1.02
5-hydroxytryptamine release into human jejunum by cholera toxin. Gut (1996) 1.01
Oral BCG vaccine in Crohn's disease. Gut (1979) 1.00
Field evaluation of a rapid, simple and inexpensive urease test for the detection of Helicobacter pylori. J Gastroenterol Hepatol (1993) 1.00
L-Arginine, nitric oxide, and intestinal secretion: studies in rat jejunum in vivo. Gut (1996) 1.00
The prevalence and aetiology of persistent diarrhoea in adults in urban Zambia. Acta Trop (1996) 0.99
Sulphadoxine-pyrimethamine therapy in Crohn's disease. Digestion (1982) 0.99
Acetate and citrate stimulate water and sodium absorption in the human jejunum. Digestion (1986) 0.99
Cancer and mutant DNA in blood plasma. Lancet (1996) 0.98
Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut (1993) 0.98
Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and tryptophan in plasma and urine by HPLC with fluorimetric detection. Biomed Chromatogr (1995) 0.98
Selective COX-2 inhibitors and human inflammatory bowel disease. Aliment Pharmacol Ther (1999) 0.97
Modulation of human upper intestinal nutrient transit by a beta adrenoreceptor mediated pathway. Gut (1992) 0.97
The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat. Br J Pharmacol (2000) 0.97
In vivo effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: a segmental perfusion study. Aliment Pharmacol Ther (1997) 0.97
A double-blind randomized trial of low-dose versus high-dose topical anaesthesia in unsedated upper gastrointestinal endoscopy. Aliment Pharmacol Ther (1996) 0.96
Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with postvagotomy diarrhoea. Gut (1988) 0.96
Factors associated with tolerance to, and discomfort with, unsedated diagnostic gastroscopy. Scand J Gastroenterol (2001) 0.96
Histopathological changes in the liver after allogeneic bone marrow transplantation. J Clin Pathol (1980) 0.96
Helicobacter pylori pore-forming cytolysin orthologue TlyA possesses in vitro hemolytic activity and has a role in colonization of the gastric mucosa. Infect Immun (2001) 0.96
Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage. Gut (1997) 0.95
Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther (1989) 0.95